9MR-32564-79678
4 vaccinations
4 coded responses
32 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 325 / FL
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Moderna
-
2021-03-08
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Just sore muscle at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-09
Dose 2 — Moderna
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Injection site reaction — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: When injection site became really, initially, it came across my neck and to my right shoulder. Next day 4/10/21, gone and just a mild headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Blister, COVID-19, Diarrhoea, Eye pain, Fatigue, Ocular hyperaemia, Pain, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid delta variant, slightly achy, extreme fatigue, mild diarrhea, eye pain, red eyes, lost taste and smell. Two weeks after Covid, purple blisters on a toe, finger and face. Also, had some loss of vision.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Dose 3 — Pfizer-BioNTech
- 2022-04-09
-
2022-09-13
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-12-13
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, Asthenia, Cough, Fatigue, Pulmonary congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Loss of taste and smell. Excessive cough and lung congestion. Fatigue and weakness that lasted around two weeks.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-09 | Moderna | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Just sore muscle at injection site.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): When injection site became really, initially, it came across my neck and to my right shoulder. Next day 4/10/21, gone and just a mild headache.
Release 10 — 6 months, dose 2
Symptoms: Covid delta variant, slightly achy, extreme fatigue, mild diarrhea, eye pain, red eyes, lost taste and smell. Two weeks after Covid, purple blisters on a toe, finger and face. Also, had some loss of vision.
Release 12 — 3 months, dose 4
Symptoms: Loss of taste and smell. Excessive cough and lung congestion. Fatigue and weakness that lasted around two weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Blister | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pulmonary congestion | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release